Logo

Paige Secures Funding from Goldman Sachs to Continue Innovation in Digital Pathology

Share this

Paige Secures Funding from Goldman Sachs to Continue Innovation in Digital Pathology

Shots:

  • Paige has completed a $70M series B funding round that included $15M in additional investment from Goldman Sachs Merchant Banking Division. The firm has so far invested $20M in Paige
  • Additionally- Healthcare Venture has also invested $5M bringing Paige’s total capital raised to over $95M.  Paige will utilize its funding to ramp up its position in transforming pathology workflows while working with pharmaceutical firms to create custom diagnostic and clinical trial solutions
  • Paige’s platform delivers technology to pathologists to increase diagnostic confidence and productivity. The tool offers an intuitive user experience- minimize IT burden and costs while ensuring patient safety and data privacy

Click here to read full press release/ article | Ref: Paige | Image: Twitter


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions